Chairman and CEO of Global Med Technologies, Inc. to Appear On CNN/FN'S "Entrepreneurs Only"; CEO To Discuss Global Med Technologies' Products and Asian Expansion.Business/Technology Editors DENVER--(BUSINESS WIRE)--May 9, 2000 Dr. Michael I Michael I, Byzantine emperor Michael I (Michael Rangabe), d. c.845, Byzantine emperor (811–13), son-in-law of Nicephorus I. He supported orthodoxy against iconoclasm and recalled Theodore of Studium from exile. . Ruxin, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Global Med Technologies, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: GLOB), will be interviewed by Tony Guida Tony Guida (born 1941) is a New York-based local television and radio personality. He is currently a news anchor for WCBS Newsradio 880 and a business correspondent for CBS News. on Thursday, May 11, at 9:30 p.m. EST, on CNN/FN's "Entrepreneurs Only" about the company's products, growth, and Asian expansion.
During the interview, Dr. Ruxin is expected to discuss the
following:
- What the company expects to accomplish through its Asian
expansion;
- What the expansion means for the future of the medical technology
industry;
- Global Med's revolutionary software systems SafeTrace Tx.com and
PeopleMed.com;
- How the new software products benefit the medical and health
industries as well as the individual patient; and
- What makes Global Med Technologies unique and why the company is
regarded as a leader in the medical technology field.
Global Med is an e-Health medical information technology company that provides information management software products and services to the healthcare industry. Wyndgate recently developed SafeTrace Tx(TM).com, an internet software system designed to meet the current and projected needs of hospital blood transfusion blood transfusion, transfer of blood from one person to another, or from one animal to another of the same species. Transfusions are performed to replace a substantial loss of blood and as supportive treatment in certain diseases and blood disorders. services. SafeTrace Tx.com offers a flexible, full-function application to integrate with Global Med's donor center management system, SafeTrace(R). SafeTrace is currently used to manage more than 20% of the nation's blood supply. Global Med recently introduced its newly incorporated PeopleMed.com, Inc. subsidiary that has developed a revolutionary software application designed to provide HMOs, third party payors, care management companies, physicians and self-insured Fortune 500 companies easy and immediate access to comprehensive clinical information for chronic disease patients. PeopleMed.com will offer chronic disease management as an Application Service Provider (ASP). By presenting the fullest picture of a patient's signs, symptoms and history, this program can help physicians and case managers intervene earlier and more effectively in a patient's care process. More information about Global Med's products can be found at www.globalmedtech.com or by callingGLOB Tom Marcinek, President and COO, at (916) 404-8413. This release may include statements constituting forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. , usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this document. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion